Lineage Cell Therapeutics (LCTX)
Develops off-the-shelf cell-replacement therapies for retinal, spinal-cord, hearing and corneal disease.
$0.9701
vs last close−0.07 (−6.72%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 46.39% | 117.32M shares | |
|---|---|---|---|
| 136 holders · as of Jun 30, 2026 | |||
| Insiders | 27.40% | 69.29M shares | |
| 2 holders · as of Nov 14, 2025 | |||
| Other | 26.21% | 66.30M shares | |
| remainder | |||
252.91M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
136 holders · 117.32M shares · 39 new positions · 64 increased · 28 reduced · 35 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Broadwood Capital Inc | 49.56M | 19.60% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 13.19M | 5.21% | +9.32M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 9.05M | 3.58% | +736.2K | Aug 13, 2026 |
| Defender Capital, LLC. | 6.60M | 2.61% | −130.7K | Jul 9, 2026 |
| Geode Capital Management, LLC | 5.30M | 2.10% | +2.78M | Aug 12, 2026 |
| Raffles Associates LP | 5.20M | 2.06% | −165.0K | Aug 17, 2026 |
| Fifth Third Bancorp | 4.60M | 1.82% | 0 | Aug 5, 2026 |
| Millennium Management LLC | 3.02M | 1.19% | −2.54M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Neal C. Bradsherincl. Broadwood Partners, L.P., Broadwood Capital, Inc. | 23.10% | 57.85M | 13D | Nov 14, 2025 |
| BlackRock, Inc. | 5.30% | 13.19M | 13G | Jul 29, 2026 |
| Chernett Jorey | 5.00% | 11.45M | 13G | Sep 26, 2025 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.